Testone
Testone is a medicine authorised by Swissmedic under authorisation number 70570. The authorisation holder is Dermapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 March 2026 and the authorisation is limited until 02 March 2031. ATC code G03BA03 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 70570 |
|---|---|
| Name | Testone |
| Full name | Testone, Injektionslösung |
| Authorisation holder | Dermapharm AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03BA03 |
| First authorisation | 03 March 2026 |
| Authorisation validity | 02 March 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Testone, Injektionslösung | B | 03 March 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Ampulle(n) | G03BA03 | 07.08.4. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Testone authorised in Switzerland?
Yes. Testone is authorised by Swissmedic under authorisation number 70570, data as of 01 September 2026. The authorisation is limited until 02 March 2031.
Which dispensing category does Testone have?
Testone is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Testone?
The authorisation holder is Dermapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.